AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 71c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of $1.58, $0.71 better than the analyst estimate of $0.87. Revenue for the quarter came in at $108.25 million versus the consensus estimate of $87.09 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• Accenture plc (ACN) PT Lowered at RBC Capital; 'Tough Macro Weighed on Results'